During the past decade, Het Oogziekenhuis Rotterdam conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Het Oogziekenhuis Rotterdam" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Oogziekenhuis Rotterdam" with 2 trials sponsored, "ProQR Therapeutics" with 2 trials sponsored, "ThromboGenics" with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Het Oogziekenhuis Rotterdam" #1 collaborator was "Dutch Kidney Foundation" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Het Oogziekenhuis Rotterdam" are "Eye Diseases" (3 trials), "Eye Diseases, Hereditary" (2 trials), "Eye Disorders Congenital" (2 trials), "Glaucoma" (2 trials) and "Retinal Disease" (2 trials). Many other conditions were trialed in "Het Oogziekenhuis Rotterdam" in a lesser frequency.

Most popular intervention types in "Het Oogziekenhuis Rotterdam" are "Drug" (8 trials), "Other" (5 trials), "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (2 trials), "Sham Procedure" (2 trials), "Aflibercept" (1 trials), "Microplasmin" (1 trials) and "Paul glaucoma drainage device (GDD)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Het Oogziekenhuis Rotterdam" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Het Oogziekenhuis Rotterdam". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Het Oogziekenhuis Rotterdam, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Het Oogziekenhuis Rotterdam, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".